Project Grant K08DA062011
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $621,186 to the University of Wisconsin - Milwaukee to examine the longitudinal impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the Adolescent Brain Cognitive Development (ABCD) Study. The project aims to investigate the role of the endocannabinoid system in...
- This Project Grant award of $811,679.00 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research on strengthening text-based warning labels on cannabis edible packages. The project aims to investigate the effectiveness of various front-of-package warning label features, such as enlarged size, contrasting colors, prominent positioning, and rotating multiple short messages, and how they interact with different package styles (branded,...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- The U.S. National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $686,692 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Medical University of South Carolina. The grant will fund an 8-week clinical trial to assess the prospective changes in patient-reported and objective functioning following reduction of cannabis use among adults with cannabis use disorder. The trial will evaluate the benefits of cannabis harm...
- The Project Grant award, provided by the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to measure the dynamic interactions between adenosine 2A receptors (A2AR) and dopamine D2 receptors (D2R) in the striatum, and investigate the impact of modulating D2R via an A2AR antagonist (caffeine) on behavior. The $404,440 award, spanning from February 2025 to January 2027, will fund the use of non-invasive neuroimaging techniques, such...
- This $720,763 Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the vulnerability to substance use among adolescents participating in the Adolescent Brain Cognitive Development (ABCD) study. The research aims to investigate how demographic, environmental, and psychological factors influence the transition from substance use initiation to regular or heavy use, while...
- This federal Project Grant award for $703,457.00, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to explore the longitudinal relationship between adolescent social media use and substance use. The project, titled "Longitudinal Pathways Between Adolescent Social Media Use and Substance Use: Informing Evidence-Based Guidance," will leverage data from the Adolescent Brain Cognitive Development (ABCD) Study...
- This $150,104 Project Grant award was provided by the National Institute on Drug Abuse (CFDA 93.279 Drug Use and Addiction Research Programs) to the University of California, San Diego (UCSD) to conduct research on the impact of nicotine exposure and escalation of use on structural and functional brain networks in adolescents. The study aims to leverage the Adolescent Brain Cognitive Development (ABCD) study dataset to investigate sex differences in how nicotine impacts brain development...
- The National Institute on Drug Abuse (NIDA) awarded a $1,383,618 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Johns Hopkins University to study the adverse effects of cannabis (primarily delta-9-tetrahydrocannabinol or THC) on prefrontal cortex maturation and cognitive function during adolescence. The project aims to investigate how microglia, a type of immune cell in the brain, mediate the impact of adolescent THC exposure on the prefrontal cortex,...
- This federal Project Grant award for $395,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund a 5-year prospective study to investigate the bidirectional relationship between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis in 60 participants aged 21-29 years, including healthy controls, moderate cannabis users, and those...
The federal Project Grant award titled "The Interactive Effects of Caffeine and Cannabis Use on Neurocognitive Outcomes in Adolescents and Young Adults" was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award of $187,777.00 will fund a longitudinal study at the University of California, San Diego (UCSD) to examine the impacts of caffeine consumption and concurrent cannabis use on cognitive trajectories in adolescents and young adults. The 5-year project, starting on September 1, 2025, will leverage data from the Adolescent Brain Cognitive Development (ABCD) study and the Protracted Understanding of Fluctuating Substance Use and Severity Study (PUFFS) to assess long-term trends in caffeine, cannabis, and other substance use, as well as their interactive effects on neurocognitive outcomes. The research aims to address gaps in the existing literature on the potential consequences of early-life caffeine exposure and concurrent substance use.